Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Fullerton › NPI 1316196892
Physician

The Pathology Group, INC.

The Pathology Group, INC. was paid $886K by Medicaid between Jan 2018 and Dec 2024, across 107 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 9.5% of everything it billed.

33Billing provider infoTHE PATHOLOGY GROUP, INC.
FULLERTON, CA 92835
33aNPI1316196892assigned 09/09/2008
28Total paid$886K
24GClaims444,905
24DCodes billed107
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in California

Rank by total paid#44 of 222
Median peer was paid$42K
This provider vs. median21×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201856,209$97K
201943,457$71K
202041,478$83K
202168,470$153K
202249,726$108K
202388,973$198K
2024incomplete96,592$177K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
88305 Level IV - Surgical pathology, gross and microscopic examination 9.5% 3,169 3,007 $84K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 9.4% 65,318 42,136 $83K
80053 Comprehensive metabolic panel 8.1% 44,201 31,300 $71K
83880 6.5% 10,853 8,904 $58K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 6.3% 989 942 $55K
84145 5.2% 11,677 10,323 $46K
80048 Basic metabolic panel (calcium, ionized) 4.8% 30,604 16,456 $43K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 3.8% 1,589 1,543 $34K
84484 3.7% 17,492 14,856 $33K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3.4% 3,064 1,730 $30K
83735 3.1% 22,130 7,711 $27K
83605 2.9% 14,609 12,088 $26K
95 more codes
84443 Thyroid stimulating hormone (TSH) 2.6% 8,002 $23K
87040 2.2% 7,665 $19K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.0% 487 $17K
83690 1.8% 14,016 $16K
85730 1.7% 12,691 $15K
80074 1.5% 1,959 $13K
85027 1.5% 11,435 $13K
82962 1.4% 3,716 $12K
80061 Lipid panel 1.4% 5,807 $12K
85610 1.3% 16,064 $12K
84100 1.2% 14,357 $11K
81001 1.2% 20,757 $11K
82948 1.1% 9,793 $10K
83036 Hemoglobin; glycosylated (A1C) 1.1% 6,304 $9K
84703 <1% 6,681 $8K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,515 $7K
80076 <1% 3,985 $5K
85379 <1% 2,841 $4K
82803 <1% 1,538 $4K
88304 <1% 215 $4K
81003 <1% 7,685 $4K
82550 <1% 3,066 $3K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,138 $3K
87077 <1% 2,086 $3K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 917 $3K
86901 <1% 6,072 $3K
84702 <1% 1,230 $3K
86900 <1% 5,901 $3K
82570 <1% 3,073 $3K
85007 <1% 4,169 $3K
87186 <1% 1,494 $2K
82140 <1% 1,111 $2K
86850 <1% 4,453 $2K
85380 <1% 2,126 $2K
84439 <1% 1,561 $2K
82728 <1% 910 $2K
88142 <1% 121 $2K
87081 <1% 2,092 $2K
82043 <1% 1,776 $2K
86780 <1% 733 $2K
82746 <1% 675 $2K
83540 <1% 1,457 $1K
87070 <1% 1,000 $1K
83550 <1% 981 $1K
81025 <1% 427 $1K
80202 <1% 522 $1K
85652 <1% 2,074 $982.24
84153 <1% 306 $909.69
83615 <1% 941 $853.84
86140 <1% 957 $733.14
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 156 $676.52
80047 <1% 584 $641.65
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 143 $625.54
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 748 $621.15
82607 <1% 261 $576.16
82553 <1% 222 $560.17
87075 <1% 338 $549.57
87205 <1% 763 $508.52
86141 <1% 301 $507.53
82010 <1% 321 $384.04
86880 <1% 355 $359.06
87493 <1% 62 $258.96
84550 <1% 374 $224.30
89051 <1% 53 $184.98
84156 <1% 250 $150.24
88341 <1% 14 $143.03
82378 <1% 44 $140.83
88342 <1% 12 $111.37
85046 <1% 122 $99.31
87102 <1% 66 $84.30
84478 <1% 94 $82.56
83970 <1% 12 $81.54
87210 <1% 107 $68.94
84300 <1% 94 $64.93
86255 <1% 13 $62.58
86308 <1% 114 $60.78
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 161 $58.00
88311 <1% 12 $55.88
87147 <1% 72 $51.07
84154 <1% 14 $41.30
85014 <1% 110 $35.42
85018 <1% 113 $35.01
83874 <1% 13 $32.67
86592 <1% 41 $27.49
84479 <1% 26 $26.29
85347 <1% 24 $21.18
87116 <1% 14 $19.66
86706 <1% 13 $18.79
82150 <1% 15 $16.75
87045 <1% 13 $13.94
83930 <1% 13 $13.54
83935 <1% 12 $11.75
87899 <1% 12 $10.88
84436 <1% 14 $10.38
87046 <1% 13 $8.96

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOONYASAMPANT, MARK (PRESIDENT)